These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12809067)

  • 1. [Donor-cell-derived acute leukemias after allogeneic bone marrow transplantation].
    Gopcsa L; Pálóczi K
    Orv Hetil; 2003 May; 144(19):907-16. PubMed ID: 12809067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
    Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
    Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
    Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
    Hertenstein B; Hambach L; Bacigalupo A; Schmitz N; McCann S; Slavin S; Gratwohl A; Ferrant A; Elmaagacli A; Schwertfeger R; Locasciulli A; Zander A; Bornhäuser M; Niederwieser D; Ruutu T;
    Haematologica; 2005 Jul; 90(7):969-75. PubMed ID: 15996934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
    Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
    Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia.
    Daly AS; Kamel-Reid S; Lipton JH; Messner HA; Kiss TL; Chun K; Busque L; Chang H
    Leuk Res; 2004 Oct; 28(10):1107-11. PubMed ID: 15289025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningioma in long-term survivors after allogeneic bone marrow transplantation.
    Meignin V; Gluckman E; Gambaraelli D; Devergie A; Ramee MP; Janin A; Socié G
    Bone Marrow Transplant; 1998 Oct; 22(7):723-4. PubMed ID: 9818703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor cell leukemia: a review.
    Wiseman DH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):771-89. PubMed ID: 20951819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
    Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
    Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
    Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
    Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T; Murase K; Yoshida M; Fujimi A; Iyama S; Kuribayashi K; Sato T; Kogawa K; Hirayama Y; Sakamaki S; Kohda K; Niitsu Y
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma of the buccal mucosa in a young adult with history of allogeneic bone marrow transplantation for childhood acute leukemia.
    Tomihara K; Dehari H; Yamaguchi A; Abe M; Miyazaki A; Nakamori K; Hareyama M; Hiratsuka H
    Head Neck; 2009 Apr; 31(4):565-8. PubMed ID: 18972418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
    Geller RB
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
    Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
    Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].
    Ji SQ; Chen HR; Wang HX; Yan HM; Liu J; Xue M; Zhu L
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):416-9. PubMed ID: 14642179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.